Profile picture of Astex

Astex

Pleasanton, CA
2 staff members
4 53 Reviews
Company Profile

Astex Pharmaceuticals, formerly SuperGen, fights for a better way to treat cancer. The company focuses on compounds in preclinical and early-stage clinical development. Its development pipeline includes candidates aiming to treat conditions such as lung cancer and leukemia. Astex Pharmaceuticals also has preclinical cancer research programs conducted in partnership with GlaxoSmithKline. Past successes include cancer compound Dacogen, which is licensed to Eisai. The company, which changed its name after acquiring UK drug developer Astex Therapeutics in 2011, plans to move its research operations to the UK while keeping its development and regulatory operations in the US.

Company size

51 to 200 Employees

Type

Company - Public

Revenue

$50 to $100 million (USD)

Industry

Biotech & Pharmaceuticals

Competitors

Unknown

Founded

1991

Company site

http://www.astx.com

Share Profile

Staff Members
avatar
CEO
0.0
Worked since Saturday, Jul 19 2025
People Also Viewed
  • logo
    Duluth, GA
    2.5
    Company size: 1 to 50
  • logo
    Culver City, CA
    2.5
    Company size: 1 to 50
  • logo
    Sherman Oaks, CA (US)
    2.5
    Company size: 1 to 50
  • logo
    New York, NY
    3.0
    Company size: 201 to 500
  • logo
    New York, NY
    2.5
    Company size: 51 to 200
  • logo
    New York, NY
    2.5
    Company size: 1 to 50